{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T06:17:50Z","timestamp":1787897870918,"version":"build-2784847793"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hemoptysis is a complication of bronchiectasis, but risk prediction in hospitalized patients remains insufficiently characterized. Existing bronchiectasis severity scores were developed to predict mortality, hospitalization, or exacerbations rather than hemoptysis. We aimed to develop and externally validate a model for in-hospital hemoptysis risk and interpret its predictors within prespecified clinical domains.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective two-center study included 320 hospitalized adults with bronchiectasis. The derivation cohort comprised 215 patients from the Second Hospital of Hebei Medical University, and the external validation cohort comprised 105 patients from Shijiazhuang People's Hospital. Hemoptysis was the primary outcome. Candidate predictors were prespecified according to clinical relevance, clinical-domain representation, and consistency of definition and availability across centers. A core logistic regression model included age, sex, smoking history, asthma, serum albumin, hemoglobin, and log10(BNP\/NT-proBNP+1); a prespecified secondary model additionally included chronic bronchitis. Discrimination, calibration, risk stratification, decision-curve analysis, and bootstrap validation were assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Hemoptysis occurred in 55 of 215 patients (25.6%) in the derivation cohort and 36 of 105 patients (34.3%) in the validation cohort. In the core model, higher serum albumin was independently associated with hemoptysis (odds ratio per 5-g\/L increase, 1.95; 95% CI, 1.29\u20132.94), whereas asthma showed an inverse association (odds ratio, 0.17; 95% CI, 0.06\u20130.51). These associations were observational and should not be interpreted as causal or protective. The core model achieved an AUC of 0.747 in the derivation cohort and 0.820 in external validation, with a Brier score of 0.177. Bootstrap validation yielded an optimism-corrected AUC of 0.707. The bronchitis-extended model achieved AUCs of 0.763 and 0.746, respectively. Across low-, intermediate-, and high-risk tertiles of the core model, observed hemoptysis rates were 2.9%, 34.3%, and 65.7%. Calibration drift was evident in the low-risk group, where the mean predicted probability was 21.4% compared with an observed rate of 2.9%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The core model showed good discrimination and risk stratification for in-hospital hemoptysis in bronchiectasis. The findings support a clinical-domain interpretation of bleeding susceptibility, while the albumin association should be regarded as observational. Because absolute risk was overestimated in the low-risk range, multicenter validation and local recalibration are required before probability-based clinical use.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1941626","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T05:33:50Z","timestamp":1787895230000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Hemoptysis risk in hospitalized patients with bronchiectasis: development and external validation of a clinical prediction model"],"prefix":"10.3389","volume":"13","author":[{"given":"Zhijing","family":"Gong","sequence":"first","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, The Second Hospital of Hebei Medical University","place":["Shijiazhuang, Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, The Second Hospital of Hebei Medical University","place":["Shijiazhuang, Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxiu","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, The Second Hospital of Hebei Medical University","place":["Shijiazhuang, Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, Shijiazhuang People\u2019s Hospital Affiliated to Hebei Medical University","place":["Shijiazhuang, Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Cai","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, The Second Hospital of Hebei Medical University","place":["Shijiazhuang, Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41572-018-0042-3","article-title":"Bronchiectasis","volume":"4","author":"Chalmers","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1700629","DOI":"10.1183\/13993003.00629-2017","article-title":"European respiratory society guidelines for the management of adult bronchiectasis","volume":"50","author":"Polverino","year":"2017","journal-title":"Eur Respir J"},{"key":"B3","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12890-018-0638-0","article-title":"Geographic variation in the aetiology, epidemiology and microbiology of bronchiectasis","volume":"18","author":"Chandrasekaran","year":"2018","journal-title":"BMC Pulm Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/S2213-2600(24)00364-3","article-title":"BE-China Registry investigators. Baseline characteristics of patients in the Chinese bronchiectasis registry (BE-China): a multicentre prospective cohort study","volume":"13","author":"Xu","year":"2025","journal-title":"Lancet Respir Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/S2213-2600(26)00057-3","article-title":"Comorbid diabetes disease severity and microbial changes in patients with bronchiectasis: a combined analysis of data from the EMBARC, EMBARC-India, Australian, and BE-China registries","volume":"14","author":"Hull","year":"2026","journal-title":"Lancet Respir Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1159\/000274492","article-title":"Massive hemoptysis: an update on the role of bronchoscopy in diagnosis and management","volume":"80","author":"Sakr","year":"2010","journal-title":"Respiration"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1701813","DOI":"10.1183\/13993003.01813-2017","article-title":"Observational, multicentre study on the epidemiology of haemoptysis","volume":"51","author":"Mondoni","year":"2018","journal-title":"Eur Respir J"},{"key":"B8","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1186\/s12890-021-01762-6","article-title":"Evaluating hemoptysis hospitalizations among patients with bronchiectasis in the United States: a population-based cohort study","volume":"21","author":"Lim","year":"2021","journal-title":"BMC Pulm Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1159\/000331501","article-title":"Early prediction of in-hospital mortality of patients with hemoptysis: an approach to defining severe hemoptysis","volume":"83","author":"Fartoukh","year":"2012","journal-title":"Respiration"},{"key":"B10","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1164\/rccm.201309-1575OC","article-title":"The bronchiectasis severity index: an international derivation and validation study","volume":"189","author":"Chalmers","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1183\/09031936.00026313","article-title":"Multidimensional approach to non-cystic fibrosis bronchiectasis: the FACED score","volume":"43","author":"Mart\u00ednez-Garc\u00eda","year":"2014","journal-title":"Eur Respir J"},{"key":"B12","doi-asserted-by":"publisher","first-page":"275","DOI":"10.2147\/COPD.S121943","article-title":"Predicting high risk of exacerbations in bronchiectasis: the E-FACED score","volume":"12","author":"Martinez-Garcia","year":"2017","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"B13","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1183\/13993003.01312-2015","article-title":"Predicting mortality in bronchiectasis using bronchiectasis severity index and FACED scores: a 19-year cohort study","volume":"47","author":"Ellis","year":"2016","journal-title":"Eur Respir J"},{"key":"B14","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s12890-022-02006-x","article-title":"A retrospective analysis of risk factors for massive hemoptysis in patients with bronchiectasis","volume":"22","author":"Luo","year":"2022","journal-title":"BMC Pulm Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s12931-023-02391-9","article-title":"Pseudomonas aeruginosa isolation is an important predictor for recurrent hemoptysis after bronchial artery embolization in patients with idiopathic bronchiectasis: a multicenter cohort study","volume":"24","author":"Wang","year":"2023","journal-title":"Respir Res"},{"key":"B16","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1186\/s12931-024-03019-2","article-title":"Multi-drug resistant Pseudomonas aeruginosa isolation is an independent risk factor for recurrent hemoptysis after bronchial artery embolization in patients with idiopathic bronchiectasis: a retrospective cohort study","volume":"25","author":"Sun","year":"2024","journal-title":"Respir Res"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1645331","DOI":"10.3389\/fmed.2025.1645331","article-title":"Bronchiectasis morphology and hemoptysis recurrence after bronchial artery embolization: a cohort study using inverse probability of treatment weighting","volume":"12","author":"Duan","year":"2025","journal-title":"Front Med (Lausanne)"},{"key":"B18","doi-asserted-by":"publisher","first-page":"102446","DOI":"10.1016\/j.jiph.2024.05.003","article-title":"Destroyed lung contributes to the recurrence of hemoptysis after bronchial artery embolization in patients with post-tuberculosis bronchiectasis","volume":"17","author":"Wang","year":"2024","journal-title":"J Infect Public Health"},{"key":"B19","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1186\/s12890-022-02198-2","article-title":"Bronchial artery embolization for the management of frequent hemoptysis caused by bronchiectasis","volume":"22","author":"Lu","year":"2022","journal-title":"BMC Pulm Med"},{"key":"B20","first-page":"1167","article-title":"Major haemoptysis in Hong Kong: aetiologies, angiographic findings and outcomes of bronchial artery embolisation","volume":"13","author":"Chan","year":"2009","journal-title":"Int J Tuberc Lung Dis"},{"key":"B21","doi-asserted-by":"publisher","first-page":"3636","DOI":"10.21037\/jtd-22-1541","article-title":"Hemoptysis as the presenting manifestation of bronchiectasis-associated hospitalization in Korea","volume":"15","author":"Seo","year":"2023","journal-title":"J Thorac Dis"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e078378","DOI":"10.1136\/bmj-2023-078378","article-title":"TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods","volume":"385","author":"Collins","year":"2024","journal-title":"Br Med J"},{"key":"B23","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12916-019-1466-7","article-title":"Calibration: the achilles heel of predictive analytics","volume":"17","author":"Van Calster","year":"2019","journal-title":"BMC Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"240055","DOI":"10.1183\/16000617.0055-2024","article-title":"Pathophysiology and genomics of bronchiectasis","volume":"33","author":"Perea","year":"2024","journal-title":"Eur Respir Rev"},{"key":"B25","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1164\/rccm.201210-1843CI","article-title":"Chronic bronchitis and chronic obstructive pulmonary disease","volume":"187","author":"Kim","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.resinv.2021.11.004","article-title":"Bronchiectasis in severe asthma and asthmatic components in bronchiectasis","volume":"60","author":"Matsumoto","year":"2022","journal-title":"Respir Investig"},{"key":"B27","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/jpen.1451","article-title":"Hypoalbuminemia: pathogenesis and clinical significance","volume":"43","author":"Soeters","year":"2019","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"B28","doi-asserted-by":"publisher","first-page":"14799731211017548","DOI":"10.1177\/14799731211017548","article-title":"Serum albumin is a predictor of respiratory hospitalization in patients with bronchiectasis","volume":"18","author":"Ju","year":"2021","journal-title":"Chron Respir Dis"},{"key":"B29","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13244-020-00877-4","article-title":"Evaluation of the bronchial arteries: normal findings, hypertrophy and embolization in patients with hemoptysis","volume":"11","author":"Almeida","year":"2020","journal-title":"Insights Imag"},{"key":"B30","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s00270-022-03127-w","article-title":"CIRSE standards of practice on bronchial artery embolisation","volume":"45","author":"Kettenbach","year":"2022","journal-title":"Cardiovasc Intervent Radiol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"307","DOI":"10.5152\/dir.2017.16454","article-title":"Bronchial artery embolization in hemoptysis: a systematic review","volume":"23","author":"Panda","year":"2017","journal-title":"Diagn Interv Radiol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1056\/NEJMra2202819","article-title":"Bronchiectasis \u2014 a clinical review","volume":"387","author":"O\u2019Donnell","year":"2022","journal-title":"N Engl J Med"},{"key":"B33","doi-asserted-by":"publisher","first-page":"411","DOI":"10.2147\/COPD.S6133","article-title":"The pathophysiology of bronchiectasis","volume":"4","author":"King","year":"2009","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"B34","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1177\/0272989X06295361","article-title":"Decision curve analysis: a novel method for evaluating prediction models","volume":"26","author":"Vickers","year":"2006","journal-title":"Med Decis Making"},{"key":"B35","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s41512-019-0064-7","article-title":"A simple, step-by-step guide to interpreting decision curve analysis","volume":"3","author":"Vickers","year":"2019","journal-title":"Diagn Progn Res"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1941626\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T05:33:51Z","timestamp":1787895231000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1941626\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,28]]},"references-count":35,"alternative-id":["10.3389\/fmed.2026.1941626"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1941626","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,28]]},"article-number":"1941626"}}